FAS and systemic lupus erythematosus: Thus, to understand the mechanism of MSCs as therapeutic for SLE, the best-suited animal model is the Fas mutated MRL/lpr and NZB/W F1 mice, which develop lupus-like syndrome very similar to human SLE and have been widely used to study the mechanism of MSC therapy [76–78].